Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02643303
Brief Title: A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab Plus PolyICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers

First Submitted : December 18, 2015
First Submitted that Met QC Criteria : December 28, 2015
First Posted : December 31, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : August 27, 2019
Last Update Posted : August 28, 2019